CST 6.41% 8.3¢ castile resources ltd

some light reading, page-18

  1. 20,544 Posts.
    lightbulb Created with Sketch. 79
    more reading....

    setback for T SPOT
    SOUTH AFRICA: Comparison of T-SPOT.TB Assay and Tuberculin Skin Test for the Evaluation of Young Children at High Risk for Tuberculosis in a Community Setting

    Pediatrics Vol. 123; No. 1: P. 38-43 (01..09) - Wednesday, February 04, 2009
    Mark P. Nicol, FCPath, PhD; Mary-Ann Davies, MBChB; Kathryn Wood, Nat Dip; Mark Hatherill, MD, FCPaed; Lesley Workman, RN; Anthony Hawkridge, MBChB, FCPHM; Brian Eley, MBChB, FCPaed; Katalin A. Wilkinson, PhD; Robert J. Wilkinson, FRCP, PhD; Willem A. Hanekom, MBChB, FCPaed; David Beatty, FCPaed, PhD; Gregory Hussey, FCPaed, PhD
    The study authors sought to compare the sensitivity of an enzyme-linked immunospot assay (T-SPOT.TB; Oxford Immunotec, Oxford, UK) and the tuberculin skin test for the detection of TB infection in very young children being evaluated for active TB in a rural community setting.

    Children with a history of TB exposure and those presenting to a local health care facility with symptoms suggesting TB were admitted to a dedicated case verification ward. T-SPOT.TB testing was performed, and the children were evaluated with a clinical exam, a TB skin test, chest X-ray, and cultures of induced sputum and gastric lavage specimens. A clinical algorithm was employed to determine the diagnosis.

    Of the 243 children (median age: 18 months) recruited, 214 (88 percent) had interpretable T-SPOT.TB results. Children age 12 months or older were more likely to have positive T-SPOT.TB results than younger children; however, TB skin test results were unaffected by age. For culture-confirmed TB, the sensitivity of the T-SPOT.TB was no better than that of the TB skin test (50 percent and 80 percent, respectively); it was poorer for the combined group of culture-confirmed and clinically probable TB (40 percent and 52 percent, respectively). In the 50 children clinically categorized as not having TB, the specificity of both the T-SPOT.TB and the TB skin test was 84 percent.

    "For young children presenting in a community setting after exposure to tuberculosis or with symptoms suggesting tuberculosis, T-SPOT.TB cannot be used to exclude active disease," the authors concluded. "The sensitivity of this assay may be impaired for very young children."
 
watchlist Created with Sketch. Add CST (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
0.005(6.41%)
Mkt cap ! $17.90M
Open High Low Value Volume
7.8¢ 8.3¢ 7.8¢ $12.47K 158.1K

Buyers (Bids)

No. Vol. Price($)
1 19230 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 31578 1
Last trade - 15.37pm 22/11/2024 (20 minute delay) ?
CST (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.